• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Iptakalim Hydrochloride

CAS No. 642407-63-4

Iptakalim Hydrochloride ( —— )

产品货号. M27888 CAS No. 642407-63-4

Iptakalim 是一种亲脂性对氨基化合物,是一种新型 ATP 敏感钾通道 (KATP) 开放剂,也是一种含有 α4β2 的烟碱乙酰胆碱受体 (nAChR) 拮抗剂。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥469 有现货
10MG ¥718 有现货
25MG ¥1410 有现货
50MG ¥2275 有现货
100MG ¥3306 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥377 有现货

生物学信息

  • 产品名称
    Iptakalim Hydrochloride
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Iptakalim 是一种亲脂性对氨基化合物,是一种新型 ATP 敏感钾通道 (KATP) 开放剂,也是一种含有 α4β2 的烟碱乙酰胆碱受体 (nAChR) 拮抗剂。
  • 产品描述
    Iptakalim, a lipophilic para-amino compound, is a novel ATP-sensitive potassium channel (KATP) opener, as well as an α4β2-containing nicotinic acetylcholine receptor (nAChR) antagonist. Iptakalim is also a K(ir) 6.1/SUR2B activator that can attenuate hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection.
  • 体外实验
    Iptakalim (Ipt) hydrochloride has been shown to reverse pulmonary resistance vascular remodeling, inhibit proliferation of pulmonary arterial smooth muscle cells (PASMCs) and airway smooth muscle cells (ASMCs), as well as protect PAECs from pathological stimulation.Iptakalim has an inhibitory effect on [Ca2+]cyt increase and the proliferation of pulmonary arterial SMCs induced by endothelin-1 through activation of KATP channels. Iptakalim (10 μM, 10 min) pretreatment of pulmonary arterial SMCs significantly prevents ransient ncrease of [Ca2+]cyt elicited by endothelin-1.Iptakalim at he concentrations of 0.1, 1, and 10 AM lowered[3H]thymidine incorporation by 19.75±4.60% (n=10), 41.20±9.49% (n=10), and 54.74±10.11% (n=10), respectively, compared with that of cells treated only with endothelin-1.
  • 体内实验
    Iptakalim (10-60 mg/kg) attenuates nicotine-evoked conditioned responding. Iptakalim also attenuates chamber activity in these nicotine test sessions..Iptakalim (60 mg/kg) pretreatment significantly reduced activity (LSD comparisons).. Animal Model:Thirty male Sprague-Dawley rats weighing 275-299 grams.Dosage:0, 10, 30, or 60 mg/kg.Administration:IP, 10 min before the start of a 4-min test session.Result:Decreased chamber activity.Dipper entries following pretreatment with 30 and 60 mg/kg Iptakalim were significantly lower than with 0 (saline) or 10 mg/kg iptakalim pretreatment (Tukey HSD tests).
  • 同义词
    ——
  • 通路
    Cell Cycle/DNA Damage
  • 靶点
    Potassium Channel
  • 受体
    Aldose reductase
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    642407-63-4
  • 分子量
    179.73
  • 分子式
    C9H22ClN
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?H2O : 25 mg/mL (139.10 mM)
  • SMILES
    Cl.CC(C)NC(C)(C)C(C)C
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Simard-Duquesne N, et al. The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats. Metabolism. 1985 Oct;34(10):885-92.
产品手册
关联产品
  • KCNQ1 activator-1?

    2-Piperidinecarboxamide, N-[4-(4-甲氧基苯基)-2-thiazolyl]-1-(苯基磺酰基)- 是一种有效的 KCNQ1 通道激活剂,可用于长 QT 综合征 (LQTS) 研究。

  • Tolbutamide

    Tolbutamide 是一种钾通道抑制剂,用于治疗 II 型糖尿病。

  • Agitoxin 2

    Potent Shaker K+ channel blocker (Ki = 0.64 nM). Also inhibits Kv1.3, Kv1.6 and Kv1.1 K+ channels (Ki values are 4, 37 and 44 pM respectively).